News | June 23, 2011

U.K.'s First Two TomoHD Systems Bring Radiotherapy to Birmingham

 June 23, 2011 — Cancer patients in the United Kingdom will soon have access to two of the world's most advanced radiotherapy treatment machines. The state-of-the-art TomoTherapy TomoHD treatment systems, to be installed at the Queen Elizabeth Hospital in Birmingham, will be the first in the U.K. and Europe's first dual installation of TomoHDs. Oncology Systems Limited (OSL) is providing the machines, after money was raised in an ongoing capital appeal by the hospital's official charity and funds provided by the University Hospitals Birmingham NHS Foundation Trust.

The two machines will be installed by the fall and the first patients will be treated before the end of 2011. Eight similar TomoTherapy HiArt radiotherapy treatment machines are already treating patients at selected hospitals in England.

The TomoHD treatment system is a combined radiotherapy machine and computed tomography (CT) scanner that delivers ultra-precise, targeted image-guided intensity modulated radiotherapy. It enables clinicians to create 3-D maps of the size and location of a tumor, plotting its exact contours and where it is in relation to sensitive tissue.

Related Content

The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.